Centurion Wealth Management
DGX icon

Centurion Wealth Management’s Quest Diagnostics DGX Stock Holding History

Centurion Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$259K Hold
1,110
– – 0.06% 238
2026
Q2 		$235K Sell
1,110
-350
-24% -$68.7K 0.06% 259
2026
Q1 		$286K Sell
1,460
-1
-0.1% -$194 0.06% 240
2025
Q4 		$254K Buy
1,461
+1
+0.1% +$182 0.06% 259
2025
Q3 		$278K Buy
+1,460
New +$259K 0.06% 235

Other funds holding DGX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Conning Inc
Conning Inc Hartford, Connecticut $3.25B AUM 18.91% 1-Year Est. Return
Cookson Peirce & Co
Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return
Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Centurion Wealth Management's DGX Position: Q3 2026 in Review

Centurion Wealth Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 1,110 shares worth $259K. The position accounts for 0.06% of the portfolio, ranked #238.

Centurion Wealth Management first reported a position in DGX in Q3 2025 and has held it in 5 quarters since. The position peaked at $286K in Q1 2026. 414 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Centurion Wealth Management held 1,110 shares of Quest Diagnostics worth $259K as of Q3 2026.
  • Centurion Wealth Management left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.06% of Centurion Wealth Management's portfolio in Q3 2026, its #238 holding.
  • Centurion Wealth Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 5 quarters since.
  • Centurion Wealth Management's Quest Diagnostics position peaked at $286K in Q1 2026.
  • 414 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.